The Science Behind GutID: Precision, Innovation, and Impact
Unlock the full potential of your health with GutID's cutting-edge technology. Our tests deliver the complete picture of your gut bacteria with precise, high resolution, strain-level insights and personalized recommendations, setting a new standard in microbiome testing. Experience science-backed results designed to transform your health and wellness.
Our Technology vs. Others
Our Titan-1 technology generates a unique “fingerprint” for each strain- even for unknown strains providing accurate and complete data for actionability and broad clinical application. For example, Without knowing the strain, there is no way to know a given strain of E.coli is toxic or harmless.
Unprecedented Microbiome Detail & Insights
GutID tests use long-read sequencing which, unlike conventional 16S or shotgun metagenomics, generates high-resolution data to retrieve truly actionable information.
Technology Published In
Featured In
Intus Bio: Innovating the Future of Microbiome Science
Intus Biosciences was founded to solve three key challenges in microbiome science: universality, specificity, and taxonomy independence. Their patented bacterial lysis ensures accurate representation of every strain in a sample, enabling precise comparisons of bacterial abundance. With advanced amplicon technology and machine learning, they deliver high-throughput, strain-level analysis that identifies both pathogenic and health-promoting bacterial signatures.
Unlike traditional methods relying on incomplete databases, Intus Bio’s innovative approach identifies and tracks novel strains, addressing the immense diversity of bacteria linked to human health. As the powerhouse behind GutID, Intus Bio is transforming microbiome research and empowering better healthcare outcomes.
About Us
Dr. Mark Driscoll, PhD - Co-Founder & Chief Scientific Officer
Dr. Mark Driscoll, a microbiologist and immunologist with over two decades of expertise, has been at the forefront of advancing gut health research. As a leader at 454 Life Sciences, he played a pivotal role in developing the GS-20—the world’s first commercial next-generation sequencing (NGS) platform—revolutionizing genetic research and diagnostics. His dedication to understanding the gut microbiome's role in wellness has earned him recognition as a published researcher and keynote speaker on global stages.
Dr. Dan Fasulo, PhD - Head of Bioinformatics & IT
Dr. Dan Fasulo, our bioinformatics innovator, has spent his career creating computational tools that power microbiome discovery. A key contributor to the GS-20 development, Dan also played a vital role in landmark genomic projects at Celera and later founded Pattern Genomics, which became part of Intus Biosciences. His work bridges science and technology to drive breakthroughs in precision health.
Elena Panzeri, MSc - Microbiome and Personalized Nutrition Practitioner & Scientific and Microbiome Innovation Consultant
Elena Panzeri, MSc, is a dedicated scientist and clinician specializing in microbiome, nutrigenetics, epigenetics, metabolomics, and precision nutrition. As a Microbiome Specialist/Personalized Nutritionist at GutID, she applies cutting-edge microbiome analysis to support personalized health interventions—spanning diet, supplementation, and lifestyle. Elena has led educational workshops and actively engages in science communication around topics such as microbial diversity, longevity microbiomics, and neuroprotective gut-brain mechanisms.